A61K 51/1072
The tumor cell being from the reproductive system
Official title: {the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate}
A61K51/1072 (The tumor cell being from the reproductive system) appears on 126 US grants and 228 published applications in this corpus.
Search patents in A61K- Granted patents
- 126
- Published applications
- 228
- Assignees
- 89
- Inventors
- 324
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 3 |
| 2002 | 1 | 7 |
| 2003 | 3 | 6 |
| 2004 | 3 | 8 |
| 2005 | 3 | 8 |
| 2006 | 2 | 10 |
| 2007 | 2 | 5 |
| 2008 | 5 | 3 |
| 2009 | 9 | 13 |
| 2010 | 5 | 6 |
| 2011 | 4 | 7 |
| 2012 | 7 | 7 |
| 2013 | 7 | 9 |
| 2014 | 9 | 12 |
| 2015 | 3 | 7 |
| 2016 | 4 | 9 |
| 2017 | 6 | 11 |
| 2018 | 2 | 10 |
| 2019 | 5 | 11 |
| 2020 | 4 | 8 |
| 2021 | 6 | 9 |
| 2022 | 8 | 14 |
| 2023 | 4 | 9 |
| 2024 | 4 | 18 |
| 2025 | 8 | 12 |
| 2026 | 2 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer22 Sep 2026US 12,741,964 B2Cornell University
- Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer21 Jul 2026US 12,685,791 B2Memorial Sloan Kettering Cancer Center
- Antibody polypeptides and uses thereof14 Oct 2025US 12,441,808 B2Fredax AB
- Therapeutic agents and uses thereof12 Aug 2025US 12,383,637 B2Janssen Biotech, Inc.
- Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same29 Jul 2025US 12,371,445 B2California Institute of Technology
- Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer1 Oct 2026US 2026/0295100 A1Memorial Sloan Kettering Cancer Center
- Engineered anti-prostate stem cell antigen fusion protein and uses thereof6 Aug 2026US 2026/0226190 A1City of Hope
- Compositions and methods for the treatment of prostate cancer30 Jul 2026US 2026/0216384 A1Janssen Biotech, Inc.
- Double targeted constructs to affect tumor kill2 Apr 2026US 2026/0091008 A1Cornell University
- Methods and reagents for tumor targeting with greater efficacy and less toxicity26 Mar 2026US 2026/0083867 A1Cornell University
Most cited
By later US patents
- Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments180US 5,716,595 AImmunomedics, Inc. · 1998
- Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy173US 6,096,289 AImmunomedics, Inc. · 2000
- Method for imaging and treating organs and tissues124US 5,697,902 AImmunomedics, Inc. · 1997
- Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy117US 6,387,350 B2Immunomedics, Inc. · 2002
- Method and kit for imaging and treating organs and tissues110US 6,331,175 B1Immunomedics, Inc. · 2001